Dr. Jennifer Ligibel on SABCS 2014 | Dana-Farber Cancer Institute

(1:54)

SABCS 2014 - Key Randomised Trials I

(26:25)

SABCS 2014 - Key Randomised Trials II

(33:29)

SABCS 2014 - Radiotherapy and the Management of Early Breast Cancer

(23:53)

SABCS 2014 - PI3 Kinase Inhibition and Endocrine Treatment

(22:5)

SABCS 2014 - Tamoxifen and Ovarian Suppression

(17:16)

Carcinoma in situ

(4:7)

SABCS 2014: \

(9:21)

ACCA SBL Pre-Seen March 2025 - Heritage Collection Buildings Museum | #CaseStudy #Meeting01

(28:55)

Ductal carcinoma in situ: Anastrozole versus tamoxifen

(5:39)

SABCS Clinical Case Discussions

(57:53)

SABCS 2014: \

(9:48)

SABCS Snippets: Artificial Intelligence in the Clinic

(6:2)

SABCS 2014: \

(11:21)

View from the Trenches: What to do Monday Morning

(1:51:27)

Compelling Teaching Cases Focused on the Management of HER2-Low and HER2-Ultralow Breast Cancer

(1:31:29)

Comment: SABCS 2014 Highlights

(7:31)

SABCS 2014 - Immunotherapy in Breast Cancer

(23:43)

SABCS 2014 - Improved Understanding of Lobular Breast Cancer

(26:9)

SABCS 2014 - Contralateral Prophylactic Mastectomy

(14:28)

SABCS 2014 - Supportive Care and Lifestyle Interventions

(17:30)

SABCS 2014: Edith A. Perez, Jacksonville, Florida (N9831 trial)

(8:33)

SABCS: What do the SOFT results mean?

(4:33)

SABCS2014: Lowering Dietary Fat Intake Reduces Death Rates in Some Women With Breast Cancer

(15:55)

SABCS 2013: Hormone Positive Therapy

(23:53)

SABCS2014 2

(16:55)

SABCS: Advocates Talk About Their Hopes for Breast Cancer Treatment in Ten Years

(1:37)

What are you looking forward to at SABCS 2021?

(33)